Then, he travelled to New York for a prescription for Xcopri, also known as cenobamate tablets. An oral medication to treat ...

Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...

Vertex Pharmaceuticals offers a buying opportunity with strong Q3 earnings, robust pipeline, and healthy financials ...

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today ...

The parents of a four-year-old boy with cystic fibrosis whose gene pairing makes him "one of 50 cases in the world" have ...

"There is a grey cloud there, but there are ways of managing that grey cloud, there are ways to plan for it and there are ...

If you’ve ever used an over-the-counter nasal spray, there’s a good chance it contained methamphetamine. It’s not the illicit ...

The provincial government announced Monday that more cystic fibrosis (CF) patients in Saskatchewan are now eligible for ...

Lauren Butler, inspired by her daughter’s battle with cystic fibrosis, takes on the London Marathon to raise funds and ...

The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and ...

In a "full circle moment," Wexton met with parents of children with disabilities and complex medical needs to discuss her ...

If you have $500, you should check out Vertex Pharmaceuticals (NASDAQ: VRTX). Here's why this biotech stock is a great candidate to buy and hold forever. First, Vertex's share price currently stands ...